Delisting risk
Bolt Biotherapeutics (BOLT)
Develops Boltbody immune-stimulating antibody conjugates for cancer.
$3.84
At close−0.23 (−5.65%)
Something off on this page? Send us feedback.
Next report
Nov 11, 2026
in 69 days
EPS estimate
−$3.52
Revenue estimate
$426.3K
Fiscal quarter
Q3 FY26
EPSReportedEstimate
Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported−$7.60−$5.80−$4.46−$3.72−$3.84−$4.31−$4.57Pending
Estimate−$7.60−$6.80−$6.40−$5.07−$4.30−$2.85−$3.39−$3.52
Surprise0.0%+14.7%+30.3%+26.6%+10.7%−51.2%−34.8%—
RevenueReportedEstimate
Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported$10.0K$1.2M$1.8M$2.2M$2.5M$26.0K$5.0KPending
Estimate$790.0K$767.5K$845.8K$820.8K$666.7K$1.5M$500.0K$426.3K
Surprise−98.7%+59.2%+113.3%+164.3%+275.0%−98.3%−99.0%—
History
| Date | Estimate | Reported | Surprise |
|---|---|---|---|
| Nov 2026 | −$3.52 | — | — |
| Aug 2026 | −$3.39 | −$4.57 | −34.8% |
| May 2026 | −$2.85 | −$4.31 | −51.2% |
| Mar 2026 | −$4.30 | −$3.84 | +10.7% |
| Nov 2025 | −$5.07 | −$3.72 | +26.6% |
The latest year is open to everyone — the 26 quarters behind it read with an account. Sign in | |||
| Aug 2025 | |||
| May 2025 | |||
| Mar 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Mar 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Mar 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Mar 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Mar 2021 | |||
| Feb 2021 | |||
| Jun 2020 | |||
| Mar 2020 | |||
| Dec 2019 | |||
| Sep 2019 | |||
| Jun 2019 | |||
| Mar 2019 | |||
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Nov 11, 2026 | −$3.52 | — | — | $426.3K | — | — | — |
| Aug 11, 2026 | −$3.39 | −$4.57 | −34.8% | $500.0K | $5.0K | −99.0% | −13.3% |
| May 12, 2026 | −$2.85 | −$4.31 | −51.2% | $1.5M | $26.0K | −98.3% | +1.1% |
| Mar 12, 2026 | −$4.30 | −$3.84 | +10.7% | $666.7K | $2.5M | +275.0% | −3.5% |
| Nov 12, 2025 | −$5.07 | −$3.72 | +26.6% | $820.8K | $2.2M | +164.3% | +0.2% |
The latest year is open to everyone — the 26 quarters behind it read with an account. Sign in | |||||||
| Aug 14, 2025 | |||||||
| May 12, 2025 | |||||||
| Mar 24, 2025 | |||||||
| Nov 12, 2024 | |||||||
| Aug 13, 2024 | |||||||
| May 14, 2024 | |||||||
| Mar 21, 2024 | |||||||
| Nov 9, 2023 | |||||||
| Aug 7, 2023 | |||||||
| May 11, 2023 | |||||||
| Mar 29, 2023 | |||||||
| Nov 10, 2022 | |||||||
| Aug 10, 2022 | |||||||
| May 12, 2022 | |||||||
| Mar 30, 2022 | |||||||
| Nov 9, 2021 | |||||||
| Aug 12, 2021 | |||||||
| May 13, 2021 | |||||||
| Mar 31, 2021 | |||||||
| Feb 5, 2021 | |||||||
| Jun 30, 2020 | |||||||
| Mar 31, 2020 | |||||||
| Dec 31, 2019 | |||||||
| Sep 30, 2019 | |||||||
| Jun 30, 2019 | |||||||
| Mar 31, 2019 | |||||||